LXRP - Lexaria Bioscience granted first European patent for DehydraTECHTM technology

Lexaria Bioscience (LXRP) receives its first-ever granted patent in Europe related to its DehydraTECHTM technology. European patent number 3164141 will be published in the European Patent Bulletin of November 11, 2020 entitled "Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof" This patent includes important method of treatment claims for a broad range of disease conditions including use of cannabinoids to treat cardiac conditions such as hypertension and neurological diseases such as Alzheimer's and Parkinson's.Licensing Opportunities

For further details see:

Lexaria Bioscience granted first European patent for DehydraTECHTM technology